|
Jun 18
|
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
|
|
May 15
|
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
|
|
May 14
|
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 12
|
13 Penny Stocks with Insider Buying in 2024
|
|
May 2
|
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
|
|
Apr 14
|
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
|
|
Mar 26
|
20 Countries with the Highest Heart Disease Deaths Per Capita
|
|
Mar 20
|
Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results
|
|
Mar 18
|
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Mar 18
|
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
|
|
Feb 26
|
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
|
|
Jan 3
|
Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Aug 9
|
Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
|
|
May 3
|
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting
|
|
May 3
|
We Think Tenaya Therapeutics (NASDAQ:TNYA) Needs To Drive Business Growth Carefully
|
|
May 2
|
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201
|